One of the key treatment goals of type 2 diabetes treatment is to reduce the risk for microvascular complications, such as retinopathy, neuropathy, and kidney diseases, through glycemic and blood pressure control. The UK Prospective Diabetes Study demonstrated that every 1% decrease in A1c was associated with improved long-term outcomes and that a sustained period of glycemic control reduced the risk for microvascular disease in patients with newly diagnosed type 2 diabetes. When implemented early in the course of disease, achieving A1c targets of < 7% has been shown to reduce microvascular complications.
Other goals are to reduce the risk for macrovascular complications, such as coronary, cerebrovascular, and peripheral vascular disease, through control of lipids and blood pressure, as well as through smoking cessation; and to reduce the risk for metabolic and neurologic complications through glycemic control.
Learn more about the goals of type 2 diabetes treatment.
Medscape © 2023 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Romesh Khardori. Fast Five Quiz: Glycemic Control in Type 2 Diabetes - Medscape - Feb 21, 2023.